Tandem Diabetes Care (TNDM): Volume dana dhuwit perusahaan

Simbol resmi perusahaan Tandem Diabetes (TNDM)

The dynamics of insulin system updates and software integrations are driving growth, as evidenced by the company's cash asset movements. Tandem Diabetes Care revenues are based on the sale of smart pumps and associated consumables. However, competition from GLP-1 drugs and pressure from insurers create margin risks. The current liquidity volume 0.44 determines this parameter level, confirming the business's financial stability.

Dana dhuwit perusahaan: Tandem Corp (TNDM) kanggo 04.07.2022 - 21.11.2026

Ringkesan rincian data analitis Tandem Diabetes Care Inc (TNDM)

Analisis wiwitan perusahaan:Tandem Corp TNDM
Produk merek Tandem Diabetes Care, Inc.

This indicator aggregates cash and cash equivalents to determine the business's ability to cover capital expenditures without resorting to expensive external debt. By analyzing the cash reserves of Tandem Diabetes Care (TNDM), an investor assesses the resilience of the Control-IQ ecosystem: a sufficient liquidity buffer guarantees the development of proprietary software and protects the business from degradation during the aggressive scaling of medical solutions.

Analisis perusahaan pesaing

Volume dana dhuwit perusahaan BSX|Dana dhuwit perusahaan EW (Edwards Lifesciences Corporation)|Dana dhuwit perusahaan ResMed RMD|Volume dana dhuwit perusahaan Insulet Corp PODD|ZBH: Dhuwit awis perusahaan|Sisa dhuwit perusahaan COO (CooperVision)|ALGN (Align Technology, Inc.) - Dhuwit awis perusahaan|Globus Medical, Inc. - Sisa dhuwit perusahaan|TMDX (TransMedics Group Inc) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Alphatec Holdings ATEC|Dana dhuwit perusahaan CryoLife (AORT)|Enovis Corporation (ENOV) - Posisi dhuwit perusahaan|Integra LifeSciences Inc. - Dhuwit awis perusahaan|Volume dana dhuwit perusahaan Establishment Labs ESTA|Beta Bionics, Inc. - Volume dana dhuwit perusahaan|Aset likuid perusahaan IRADIMED Corp IRMD|Embecta (EMBC) - Dana dhuwit perusahaan|Total volume dana dhuwit perusahaan AXGN (Axogen Surgical)|Dana dhuwit perusahaan si-bone.com|Dhuwit awis perusahaan Orthofix Medical Inc. (OFIX)|Dana dhuwit perusahaan Bioventus Corp (BVS)|KIDS - Cadangan dhuwit perusahaan|Dana dhuwit perusahaan Treace Medical Concepts TMCI|SRTA: Dhuwit awis lan setara dhuwit awis perusahaan|CARL: Dhuwit awis perusahaan|rxsight.com - Gunggung dana dhuwit perusahaan|CLPT: Volume dana dhuwit perusahaan|STXS - Aset likuid perusahaan|STIM (neurostar.com) - Volume dana dhuwit perusahaan|Sight Sciences, Inc (SGHT) - Aset likuid perusahaan|Volume dana dhuwit perusahaan OBIO|Aset likuid perusahaan Anika Therapeutics Inc.|Dana dhuwit perusahaan InspireMD, Inc. NSPR|Sisa dhuwit perusahaan ZJYL|VANI - Dana dhuwit perusahaan|Xtant Medical Holdings, Inc. - Gunggung dana dhuwit perusahaan|NeuroOne (NMTC) - Dana dhuwit perusahaan|Modular Med (MODD) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan Myomo, Inc|Dhuwit awis perusahaan Envoy Medical (COCH)|Volume dana dhuwit perusahaan VVOS|NVNO (enVVeno Corp) - Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan SINT (Sintx Technologies)|TNON: Dhuwit awis lan setara dhuwit awis perusahaan|Lifeward - Volume dana dhuwit perusahaan|Sisa dhuwit perusahaan AMIX (Autonomix Medical)|IVF: Volume dana dhuwit perusahaan|Posisi dhuwit perusahaan Bone Biologics Corporation BBLG|Dhuwit awis perusahaan AXNX|BIOLASE, Inc. (BIOL) - Aset likuid perusahaan|Volume dana dhuwit perusahaan DYNT|Aset likuid perusahaan Paragon 28|Volume dana dhuwit perusahaan INVO (INVO Bioscience, Inc.)